GENMAB A/S — TTAB Proceedings
GENMAB A/S is a party to 13 TTAB proceedings.
Proceedings
- Proceeding 79395718 — Extensions of Time to Oppose, Terminated (filed 2025-05-28) against Rehabilitation Institute of Chicago as defendant
- Proceeding 91274501 — Oppositions, Terminated (filed 2022-02-14) against Biocytogen Pharmaceuticals (Beijing) Co. as plaintiff
- Proceeding 88553807 — Extensions of Time to Oppose, Terminated (filed 2021-09-15) against BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO. as plaintiff
- Proceeding 85331519 — Extensions of Time to Oppose, Terminated (filed 2011-12-01) against Agouron Pharmaceuticals, Inc. as plaintiff
- Proceeding 91190242 — Oppositions, Terminated (filed 2009-05-15) against Novartis AG as plaintiff
- Proceeding 91186100 — Oppositions, Terminated (filed 2008-08-25) against Johnson & Johnson as plaintiff
- Proceeding 77547900 — Extensions of Time to Oppose, Terminated (filed 2008-12-11) against Novartis AG as plaintiff
- Proceeding 77119483 — Extensions of Time to Oppose, Terminated (filed 2008-10-09) against HumanZyme Inc. as plaintiff
- Proceeding 77129624 — Extensions of Time to Oppose, Terminated (filed 2008-03-19) against Johnson & Johnson as plaintiff
- Proceeding 78742649 — Extensions of Time to Oppose, Terminated (filed 2007-02-08) against Rincon Pharmaceuticals, Inc. as plaintiff
- Proceeding 76355454 — Extensions of Time to Oppose, Terminated (filed 2003-01-24) against MedImmune, Inc. as plaintiff
- Proceeding 76339901 — Extensions of Time to Oppose, Terminated (filed 2002-08-22) against Aspen Veterinary Resources, Ltd. as plaintiff
- Proceeding 76214894 — Extensions of Time to Oppose, Terminated (filed 2002-03-28) against Genesis Medical, Incorporated as plaintiff
Marks in These TTAB Matters
Recent Live Filings
- Trademark 79447081 — Pending, filed 2026-01-22
- RYNLEY — Pending, filed 2026-01-22
- Trademark 79447082 — Pending, filed 2026-01-22
- HUMAX — Pending, filed 2025-11-25
- BOUND FOR BOLD PROGRESS — Pending, filed 2025-10-07
- RAINFOL — Registered, filed 2025-06-27
- ABBIL1TY — Registered, filed 2024-02-15
- FORTYSSIMO — Registered, filed 2024-01-18
- EXTRA[NOT]ORDINARY — Registered, filed 2023-09-22
- RINA-S — Registered, filed 2023-06-21
- RINA-S — Registered, filed 2023-06-21
- RINA-S — Registered, filed 2023-06-21
- MY NAVCARE PATIENT SUPPORT BY GENMAB — Registered, filed 2023-05-15
- MYNAVCARE BY GENMAB — Registered, filed 2023-05-15
- MY NAVCARE BY GENMAB — Registered, filed 2023-05-15
Common TTAB Counterparties
- BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO. — 2 proceedings
- Johnson & Johnson — 2 proceedings
- Novartis AG — 2 proceedings
- Agouron Pharmaceuticals, Inc. — 1 proceedings
- Aspen Veterinary Resources, Ltd. — 1 proceedings
- Genesis Medical, Incorporated — 1 proceedings
- HumanZyme Inc. — 1 proceedings
- MedImmune, Inc. — 1 proceedings
- Rehabilitation Institute of Chicago — 1 proceedings
- Rincon Pharmaceuticals, Inc. — 1 proceedings
Recent TTAB Timeline
- 2025-08-26: 79395718 — EXTENSION OF TIME GRANTED involving Rehabilitation Institute of Chicago
- 2025-08-26: 79395718 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Rehabilitation Institute of Chicago
- 2025-05-28: 79395718 — EXTENSION OF TIME GRANTED involving Rehabilitation Institute of Chicago
- 2025-05-28: 79395718 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Rehabilitation Institute of Chicago
- 2024-10-21: 91274501 — TERMINATED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-10-21: 91274501 — BOARD'S DECISION: DISMISSED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-10-11: 91274501 — D RESP TO BD ORDER/INQUIRY involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-09-11: 91274501 — RESPONSE DUE 30 DAYS (DUE DATE) involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-09-03: 91274501 — MOT TO AMEND APPLICATION involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-06-11: 91274501 — REQ FOR PROG ON SETTL - SUSPENDED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-06-07: 91274501 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-06-03: 91274501 — TRIAL DATES REMAIN AS SET involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-05-28: 91274501 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-05-22: 91274501 — PROCEEDINGS RESUMED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-04-09: 91274501 — SUSPENDED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2024-02-14: 91274501 — MOT TO AMEND APPLICATION involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-11-16: 91274501 — EXTENSION OF TIME GRANTED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-11-16: 91274501 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-08-21: 91274501 — EXTENSION OF TIME GRANTED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-08-21: 91274501 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-05-15: 91274501 — EXTENSION OF TIME GRANTED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-05-15: 91274501 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-03-14: 91274501 — SUSPENDED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2023-03-14: 91274501 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2022-12-19: 91274501 — SUSPENDED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2022-12-19: 91274501 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2022-09-21: 91274501 — SUSPENDED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2022-09-21: 91274501 — P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2022-07-14: 91274501 — EXTENSION OF TIME GRANTED involving Biocytogen Pharmaceuticals (Beijing) Co.
- 2022-07-14: 91274501 — P'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Biocytogen Pharmaceuticals (Beijing) Co.